Schedule 13G ownership disclosure

Amneal Pharmaceuticals Inc

Class A Common Stock, par value $0.01 per share · CUSIP: 03168L105

Event date: 2024-09-30

Filing-level shares
21,491,881.00
Percent of class
6.9%
  • UBS Group AG

    Shares: 21,491,881.00 · Class: 6.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001610520-24-000160
Form type
SCHEDULE 13G
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Oct 30, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub